The 10th JSH INTERNATIONAL SYMPOSIUM 2019 in Ise-Shima

The 10th JSH INTERNATIONAL SYMPOSIUM 2019 in Ise-Shima

Program

pdf Program

Tentative Program

Thursday, 16 May, 2019
19:30~ Presidential Reception at Toba Aquarium
*The aquarium will be reserved from 19:00 for our reception.
*All participants of the symposium will be welcomed regardless whether or not you are a chair or a speaker.


Friday, 17 May, 2019  
8:30~8:35 Opening Remarks
8:35~9:05 Special Session 1
Chair Dr. Kinuko Mitani ( Dokkyo Medical University School of Medicine )
Speaker Dr. Hiroto Inaba ( St. Jude Children’s Research Hospital, Memphis, Tennessee, USA )
Precision Medicine in Pediatric Acute Lymphoblastic Leukemia: A Strategy to Cure All Patients and Decrease Adverse Effects
9:15~10:35 Asian Pacific Session 1 : Bone Marrow Failure
Chair Dr. Shouichi Ohga ( Kyushu University )
Dr. Yoshiyuki Takahashi ( Kyushu University Hospital )
Speaker Dr. Atsushi Narita ( Nagoya University Graduate School of Medicine )
Randomized Trial of Two Dosages of Rabbit Antithymocyte Globulin in Patients with Aplastic Anemia
Dr. Jing Chen ( Shanghai Jiao Tong University School of Medicine )
Upfront alternate donor HSCT for patients with severe aplastic anemia:multi-center prospective clinical trial outcome
Dr. Ken Ishiyama ( Kanazawa University Hospital )
Factors Affecting Response to Eltrombopag in Patients with Refractory Aplastic Anemia
Dr. Jong-Wook Lee ( Seoul St.Mary’s Hospital, The Catholic University of Korea, Korea )
Safety and Efficacy of Romiplostim in Aplastic Anemia Refractory to Immunosuppressive Therapy
9:15~10:35 Asian Pacific Session 2 : Neoplastic Lymphoid Cells
Chair Dr. Shigeru Chiba ( University of Tsukuba )
Dr. Motoko Yamaguchi ( Mie University Graduate School of Medicine )
Speaker Dr. Kotaro Arita ( University of Toyama Graduate School of Medicine and Pharmeceutical Sciences )
Establishment of a Mouse Model of B-cell Lymphoma Using an In Vitro Retroviral Transduction System.
Dr. Constantine S Tam ( St Vincent Hospital, Peter MacCallum Cancer Center and University of Melbourne, Melbourne, Victoria, Australia )
Exploiting Weaknesses in the Malignant Lymphoid Cell for Targeted Therapy
Dr. Mamiko Sakata-Yanagimoto ( University of Tsukuba )
Genome-based medicine in peripheral T-cell lymphomas.
Dr. Yok-Lam Kwong
10:35~10:45 Break
10:45~12:25 Plenary Session 1 : T Cells ( Normal, Pathologic, and Modified ) and Antigen-Presenting Cells
Chair Dr. Itaru Matsumura ( Kindai University Faculty of Medicine )
Dr. Norimitsu Kadowaki ( Kagawa University )
Speaker Dr. Ken-ichi Matsuoka ( Okayama University )
In Vivo Modulation of Regulatory and Effector T cell Homeostasis for Maximization of GVL Effect in Allogeneic HSCT
Dr. Zwi N. Berneman ( Antwerp University Hospital and University of Antwerp, Antwerp, Belgium )
Dendritic Cell Vaccination: Correlation Of Clinical Effects With T-Cell Response.
Dr. Naoki Hosen ( Osaka University Graduate School of Medicine )
The Activated Conformation of Integrin b7 is a Novel Multiple Myeloma–Specific Target for CAR T-cell Therapy
Dr. Madhav V. Dhodapkar ( Emory University, Atlanta, GA, USA)
Targeting Tissue Residence And Innate Immunity Towards Protective Immunity
12:25~12:35 Break
12:35~13:20 Luncheon Seminar 1 ( Co-Sponsored by Eisai Co., Ltd )
Chair Dr. Kinuko Mitani ( Dokkyo Medical University School of Medicine )
Speaker Dr. Ulrich Jaeger ( Medical University of Vienna, Austria )
Precision medicine of lymphoma based on genetics
Luncheon Seminar 2 ( Co-Sponsored by Chugai Pharmaceutical Co., Ltd. )
Chair Dr. Norio Komatsu ( Juntendo University Schiil of Medicine )
Speaker Dr. Anthony Letai ( Dana-Farber Cancer Institute, Harvard Medical School, USA )
Future prospects for targeting apoptosis in hematopoietic malignancies
13:20~14:10 Poster Viewing
14:10~15:50 JSH-ASH Joint Session : Normal and Pathologic Hematopoietic Stem Cells
Chair Dr. Yasushi Miyazaki ( Nagasaki University )
Dr. Kazuya Shimoda ( University of Miyazaki )
Speaker Dr. Fumihiko Ishikawa ( RIKEN Center for Integrative Medical Sciences )
Developing therapeutic strategies for genetically-complex acute myeloid leukemia
Dr. Ravi Majeti ( Stanford University )
Stem Cells in Human AML
Dr. Seishi Ogawa
Dr. Anthony Letai ( Dana-Farber Cancer Institute, Harvard Medical School, USA )
Guiding blood cancer therapy with mitochondrial BH3 profiling
15:10~16:05 Break
16:05~17:45 Plenary Session 2 : Ex Vivo Generation of Blood Cells
Chair Dr. Yoshinobu Maeda ( Okayama University Hospital )
Dr. Yasushi Miyazaki ( Nagasaki University )
Speaker Dr. Shin-ichiro Fujii ( RIKEN Center for Integrative Medical Sciences )
Establishment of A New Therapeutic Cancer Vaccine Inducing Multifunctional Immunity, “Artificial Adjuvant Vector Cells (aAVC)”
Dr. Jeffrey Miller ( University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota, USA )
Novel Ways To Activate NK Cells With Specificity To Treat Cancer.
Dr. Koji Eto ( CiRA, Kyoto University,  Graduate School of Medicine, Chiba University )
Turning Stem Cells into Platelets for Next Generation Transfusion
Dr. Irwin D. Bernstein ( Fred Hutchinson Cancer Research Center / University of Washington )
Notch signaling: Enhancing the ex vivo generation of cells for therapeutic application
17:45~17:55 Break
17:55~18:25 Oral Session : Hematological Malignancies and Their Therapies, Clonal Hematopoiesis
Chair Dr. Tetsuya Nosaka ( Mie University Graduate School of Medicine )
Dr. Masahiro Hirayama ( Mie University Graduate School of Medicine )
Speaker TBC
TBC
TBC
  Welcome Reception


Saturday, 18 May, 2019  
8:00~8:45 Morning Seminar 1 ( Co-Sponsored by Novartis Pharma K.K)
Chair Dr. Yuzuru Kanakura ( Sumitomo Hospital )
Speaker Dr. Itaru Matsumura ( Kindai University Faculty of Medicine )
Current status and future of CML treatment
Morning Seminar 2 ( Co-Sponsored by Pfizer Japan Inc )
Chair Dr. Hitoshi Kiyoi ( Nagoya University Graduate School of Medicine )
Speaker Dr. Takahiro Yamauchi ( Department of Hematology and Oncology Nagoya University Graduate School of Medicine  )
The Beginning of the New Era of R/R ALL treatment with BESPONSA(Inotuzumab ozogamicin
8:45~8:55 Break
8:55~9:25 Special Session 2 : My Research Career in the US Medical System.
Chair Dr. Yuzuru Kanakura ( Osaka University )
Speaker Dr. Makio Ogawa ( Medical University of South Carolina, USA)
My Research Career in the US Medical System.
9:25~9:40 Break
9:40~11:20 JSH-EHA Joint Session : Normal and Pathologic B Cells
Chair Dr. Ulrich Jaeger ( Medical University of Vienna, Austria )
Dr. Junji Suzumiya ( Shimane University Hospital )
Speaker Dr. Tomohiro Kurosaki ( Osaka University )
Function Of Memory B Cells And Their Generation Mechanism
Dr. Hermann Einsele ( University Hospital Würzburg, Germany )
T Cell Redirecting Strategies In The Treatment Of B-Cell And Myeloid Malignancies 
Dr. Koji Kato ( CiRA, Kyoto University, Graduate School of Medicine, Chiba University )
Turning Stem Cells into Platelets for Next Generation Transfusion
Dr. Ulrich Jaeger ( Medical University of Vienna, Austria )
Drug Sensitivity Testing for Treatment-Decisions in B-Cell-Lymphomas.
11:20~11:30 Break
11:30~12:15 Luncheon Seminar 3 (Co-Sponsored by Bristol-Myers Squibb K.K. )
Chair Dr. Koichi Akashi ( Kyushu University )
Speaker Dr. Hermann Einsele ( University Hospital Würzburg, Germany )
Immunotherapy for multiple myeloma targeting CD38, SLAMF7 and the future
Luncheon Seminar 4 ( Co-Sponsored by Nippon Shinyaku Co.,Ltd. )
Chair Dr. Masahiro Kizaki (Saitama Medical Center, Saitama Medical University)
Speaker Dr. Ravi Majeti ( Stanford University )
Clonal Evolution in Human AML
12:15~12:25 Break
12:25~12:55 Special Session 3 : Adoptive cell therapy with gene engineered T cells - specificity, constructs, and cells 
Chair Dr. Koichi Akashi ( Kyushu University )
Speaker Dr. Hiroshi Shiku ( Mie University Graduate School  of Medicine )
Adoptive cell therapy with TCR-gene engineered T cells and Beyond
12:55~13:00 Closing Remarks
Page Top